$SGRY

Surgery Partners: Q2 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q2 loss of $15 million, or 12 cents per share. Adjusted earnings were 10 cents per share, and revenue was $848.9 million. The company expects full-year revenue of $3.35 billion to $3.45 billion, according to its earnings release.

Original reporting
Published Aug 11, 2026, 12:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 12:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SGRY
Neutral
medium confidence
Mentioned
$SGRY
Relevance
7/10
alphai data visualization · based on local3news.com
Decision brief

The 30-second read

$SGRYNeutralMed
01

Why it matters

Traders can use the provided Q2 revenue and EPS figures plus the FY revenue range to update models and near-term positioning.

02

Market read

Company-specific earnings and guidance are actionable for SGRY estimate revisions and sentiment.

03

What to watch

The article does not mention margins, cash flow, leverage, or payer mix, which are often the real drivers of surgical facilities valuation.

Relevance 7/10Novelty 6/10Timing: reported Monday Q2 results and full-year revenue guidance

Background

Surgery Partners is a surgical facilities operator; this is an earnings snapshot with adjusted and non-recurring cost context plus FY revenue guidance.

Company-level read

Ticker impact

$SGRYNeutralMedium confidence
Context

Surgery Partners reported Q2 results and issued full-year revenue guidance of $3.35B to $3.45B.

Expected impact

Likely modest volatility around the open as traders reprice FY revenue expectations versus prior consensus.

Evidence & confidence

The article provides concrete EPS, adjusted EPS, revenue, and a full-year revenue range, but no surprise magnitude versus consensus is stated.

Market effects

Adds incremental datapoint for demand and pricing trends in surgical facilities and healthcare services.

No specific regional read-through beyond US healthcare services.

Limited, as the disclosure is company-specific and US-focused.

Counterpoint

If the adjusted EPS and guidance are broadly in line with expectations, the stock reaction may fade quickly after the initial earnings digestion.

Key entities

  • Surgery Partners Inc.

    Reported Q2 loss of $15M (12 cents/share) and adjusted EPS of 10 cents, with revenue of $848.9M, and guided FY revenue to $3.35B-$3.45B.

Related articles

$SGRYMed

Surgery Partners Q2 Earnings Call Highlights

Surgery Partners (NASDAQ:SGRY) reported Q2 same-facility revenue up 4.9% for the first half, driven by a 0.8% case increase and 4% net revenue per case. Management said commercial payer mix fell to about 49% of Q2 net revenue, with government payments rising. The company signed agreements to sell Idaho Falls assets for about $795M gross consideration and reaffirmed 2026 guidance excluding the deal.

$SGRYMed

Surgery Partners shares edge lower despite Q2 revenue beat

Surgery Partners (NASDAQ:SGRY) shares fell 0.71% pre-market after Q2 results were mixed. Revenue rose to $848.9M, above the $830.05M forecast, and same-facility revenue grew 5%. Adjusted EPS was $0.10 vs $0.06 consensus, but GAAP net loss was $0.12/share. Adjusted EBITDA fell to $125.2M. Company reaffirmed 2026 revenue $3.35B-$3.45B and adjusted EBITDA at least $530M.

$SGRYMedAI 8/10

Surgery Partners Q2 2026 slides show 5% revenue growth, Idaho exit

Surgery Partners (NASDAQ:SGRY) reported Q2 2026 revenue of $848.9M, above an $830.05M estimate, but posted an adjusted loss of $0.12 per share versus a $0.06 profit expectation. Same-facility revenue grew 5.0% on 4.8% rate growth. The company reaffirmed 2026 guidance: $3.35B to $3.45B revenue and at least $530M adjusted EBITDA, excluding the pending Idaho Falls divestiture.

$SGRYMedAI 8/10

Surgery Partners, Inc. (SGRY): Results of Operations and Financial Condition

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q22026earningsre.htm EX-99.1 Document Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS REAFFIRMS FULL YEAR 2026 GUIDANCE BRENTWOOD, Tenn., August 10, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or t

Surgery Partners: Q2 Earnings Snapshot — alphai